Mineralocorticoid receptor antagonists (MRAs) reduced the risk of cardiovascular death or heart failure (HF) hospitalization in patients with HF and...
Vous n'êtes pas connecté
- English
- Français
- عربي
- Español
- Deutsch
- Português
- русский язык
- Català
- Italiano
- Nederlands, Vlaams
- Norsk
- فارسی
- বাংলা
- اردو
- Azərbaycan dili
- Bahasa Indonesia
- Հայերեն
- Ελληνικά
- Bosanski jezik
- українська мова
- Íslenska
- Türkmen, Түркмен
- Türkçe
- Shqip
- Eesti keel
- magyar
- Қазақ тілі
- Kalaallisut ; kalaallit oqaasii
- Lietuvių kalba
- Latviešu valoda
- македонски јазик
- Монгол
- Bahasa Melayu ; بهاس ملايو
- ဗမာစာ
- Slovenščina
- тоҷикӣ ; toğikī ; تاجیکی
- ไทย
- O'zbek ; Ўзбек ; أۇزبېك
- Tiếng Việt
- ភាសាខ្មែរ
- རྫོང་ཁ
- Soomaaliga ; af Soomaali
Maroc - KNOWRIDGE.COM - A La Une - 03/Aug 15:31
Scientists find hidden link between obesity and heart failure
A small study led by researchers at Johns Hopkins Medicine, published on July 25th in Nature Cardiovascular Research, has uncovered how obesity affects muscle structure in patients with a specific type of heart failure known as heart failure with preserved ejection fraction (HFpEF). HFpEF makes up more than half of all heart failure cases globally. […]
Articles similaires
Mineralocorticoid receptor antagonists benefit heart failure patients across ejection fractions
news.medical.net - 02/Sep 12:45
Mineralocorticoid receptor antagonists (MRAs) reduced the risk of cardiovascular death or heart failure (HF) hospitalization in patients with HF and...
New Pooled Analysis Published in The Lancet Demonstrated Reduced Risk of Combined CV Death or Worsening Heart Failure with Semaglutide
drugs.com - 30/Aug 03:09
PLAINSBORO, N.J., Aug. 30, 2024 /PRNewswire/ -- Today, The Lancet published a new pooled, participant-level analysis of patients with heart failure...
New Pooled Analysis Published in The Lancet Demonstrated Reduced Risk of Combined CV Death or Worsening Heart Failure with Semaglutide
drugs.com - 30/Aug 03:09
PLAINSBORO, N.J., Aug. 30, 2024 /PRNewswire/ -- Today, The Lancet published a new pooled, participant-level analysis of patients with heart failure...
New pooled analysis published in The Lancet demonstrated reduced risk of combined CV death or worsening heart failure with semaglutide
drugs.com - 03/Sep 04:09
PLAINSBORO, N.J., Sept. 3, 2024. The Lancet has published a new pooled, participant-level analysis of patients with heart failure with mildly reduced...
Semaglutide Reduces Risk for MACE in Patients With Obesity and Heart Failure
drugs.com - 28/Aug 14:08
WEDNESDAY, Aug. 28, 2024 -- Semaglutide reduces the risk for major adverse cardiovascular events (MACE) and composite heart failure end points...
Mineralocorticoid receptor antagonists reduce risk of cardiovascular events in patients with heart failure
news.medical.net - 03/Sep 11:44
MRAs significantly lower the risk of cardiovascular death and HF hospitalization in heart failure patients.
Cryoballoon ablation as effective as radiofrequency for atrial fibrillation in heart failure patients
news.medical.net - 02/Sep 12:37
Cryoballoon (CB) ablation is as effective at reducing recurrences of atrial fibrillation (AF) and atrial tachycardia (AT) at 1-year, when compared to...
Cryoballoon ablation as effective as radiofrequency for atrial fibrillation in heart failure patients
news.medical.net - 02/Sep 12:37
Cryoballoon (CB) ablation is as effective at reducing recurrences of atrial fibrillation (AF) and atrial tachycardia (AT) at 1-year, when compared to...
What the unique shape of the human heart tells us about our evolution
rawstory.com - 29/Aug 11:12
Mammals, from the mighty blue whale to the tiny shrew, inhabit nearly every corner of our planet. Their remarkable adaptability to different...
Les derniers communiqués
-
Aucun élément